Get the Stockscreener App
1.10
0.92%
0.01
Silo Pharma Inc stock is traded at $1.10, with a volume of 73,346.
It is up +0.92% in the last 24 hours and down -5.98% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
See More
Previous Close:
$1.09
Open:
$1.07
24h Volume:
73,346
Relative Volume:
0.01
Market Cap:
$4.93M
Revenue:
$72,100
Net Income/Loss:
$-3.60M
P/E Ratio:
-0.6548
EPS:
-1.68
Net Cash Flow:
$-3.37M
1W Performance:
+5.77%
1M Performance:
-5.98%
6M Performance:
-43.59%
1Y Performance:
-34.13%
1-Day Range:
$1.05
$1.10
1-Week Range:
$1.03
$1.10
52-Week Range:
$0.841
$4.50
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Silo Pharma Inc Stock (SILO) Latest News
SILO Pharma (NASDAQ:SILO) Stock Quotes, Forecast and News Summary - Benzinga
Exclusive Come Home Trailer Previews Horror Thriller Movie Featuring Silo Stars - ComingSoon.net
Egypt: General Company for Silos’s profits rise 45.6% YoY in FY2023/24 - ZAWYA
Silvis Materials Awarded $1 Million NSF SBIR Phase II Grant to Reduce Emissions in Packaging and Building - EIN News
FDA Grants Accelerated Approval to Gilead’s Livdelzi for Primary Biliary Cholangitis - The Healthcare Technology Report.
Serpin Pharma and Uniklinikum Erlangen Team Up for a Clinical Trial to Prevent Acute Kidney Injury - EIN News
New Silo Season 2 Character Is Very Closely Copying An Iconic 2000s TV Show - Screen Rant
Roli Mosimann (Swans / Wiseblood / The The) has died - Brooklyn Vegan
SosMula Finally Delivers "SLEEZ RELIGION" - HotNewHipHop
Silo season 2: Apple TV Plus release date, likely cast, story rumors, and more news about the sci-fi show's return - TechRadar
Silo Pharma completes pre-IND meeting with FDA on SPC-15 for PTSD - BioWorld Online
Financial Metrics Exploration: Understanding SILO Pharma Inc (SILO) Through Ratios - The Dwinnex
SILO Pharma Inc [SILO] Insider Activity: An Update for Investors - Knox Daily
Silo Pharma moves forward with PTSD treatment SPC-15 - Investing.com
Silo Pharma moves forward with PTSD treatment SPC-15 By Investing.com - Investing.com Australia
SILO Pharma Inc Inc. (SILO) Price Performance: A Technical Analysis Perspective - The InvestChronicle
SILO’s price-to-sales ratio: Is it a good investment opportunity? - US Post News
Silo Pharma moves forward with PTSD treatment SPC-15 By Investing.com - Investing.com Canada
Silo Pharma Outlines Strategic Direction and Innovative Pipeline - TipRanks
Silo Pharma Announces Completion of FDA Pre-IND Meeting to - GlobeNewswire
Silo Pharma (NASDAQ:SILO) Shares Down 6% - Defense World
Adversity is less terrifying than hope: SILO Pharma Inc (SILO) - SETE News
SILO Pharma Inc (SILO)’s stock price range in the last year - US Post News
Metric Deep Dive: Understanding SILO Pharma Inc (SILO) Through its Ratios - The Dwinnex
SILO Pharma Inc [SILO] Investment Guide: What You Need to Know - Knox Daily
SILO’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Silo Pharma advances ketamine implant for chronic pain treatment - Investing.com India
Silo Pharma advances ketamine implant for chronic pain treatment - Investing.com
Silo Pharma Shares Jump 11% on Ketamine-Treatment Partnership - MarketWatch
Silo Pharma advances ketamine implant for chronic pain treatment By Investing.com - Investing.com UK
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic - GlobeNewswire
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic - Yahoo Finance
SILO Pharma Inc’s latest rating changes from various analysts - Knox Daily
Silo Pharma partners with WuXi AppTec for MS peptide study - Investing.com India
Closing Figures: SILO Pharma Inc (SILO)’s Negative Finish at 1.18, Down -13.24 - The Dwinnex
Silo Pharma partners with WuXi AppTec for MS peptide study By Investing.com - Investing.com UK
SILO’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
How does SILO’s price to cash per share ratio compare in the market? - US Post News
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide - GlobeNewswire
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide - Yahoo Finance
Taking on analysts’ expectations and winning: SILO Pharma Inc (SILO) - SETE News
Examining SILO Pharma Inc (SILO) more closely is necessary - US Post News
Investing in SILO Pharma Inc (SILO): What You Must Know - Knox Daily
SILO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Financial Metrics Unveiled: SILO Pharma Inc (SILO)’s Key Ratios in the Spotlight - The Dwinnex
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference - GlobeNewswire
SILO Pharma Inc [SILO] CEO and President makes an insider purchase of 4,438 shares worth 4926.0. - Knox Daily
Financial Fitness Check: Examining SILO Pharma Inc (SILO)’s Key Ratios - The Dwinnex
ADIL Stock A Beacon of Hope: A Deep Dive into Adial Pharmaceuticals - All Finance Times
How does SILO Pharma Inc (SILO) change from a tortoise to a hare? - SETE News
Understanding the Risks of Investing in SILO Pharma Inc (SILO) - Knox Daily
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):